Therapeutic angiogenesis for cardiovascular disease

<p>Abstract</p> <p>The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to induce therapeutic angiogenesis. The results of numerous animal studies and clinical trials have...

Full description

Bibliographic Details
Main Authors: D'Amore Patricia A, Ng Yin-Shan
Format: Article
Language:English
Published: BMC 2001-10-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
Online Access:http://dx.doi.org/10.1186/cvm-2-6-278
_version_ 1818482784069484544
author D'Amore Patricia A
Ng Yin-Shan
author_facet D'Amore Patricia A
Ng Yin-Shan
author_sort D'Amore Patricia A
collection DOAJ
description <p>Abstract</p> <p>The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to induce therapeutic angiogenesis. The results of numerous animal studies and clinical trials have offered promise for new treatment strategies for various ischemic diseases. Increased understanding of the cellular and molecular biology of vessel growth has, however, prompted investigators and clinicians alike to reconsider the complexity of therapeutic angiogenesis. The realization that formation of a stable vessel is a complex, multistep process may provide useful insights into the design of the next generation of angiogenesis therapy.</p>
first_indexed 2024-12-10T11:51:33Z
format Article
id doaj.art-45aa073cbb26470aab4d516c39ffbd0f
institution Directory Open Access Journal
issn 1468-6708
language English
last_indexed 2024-12-10T11:51:33Z
publishDate 2001-10-01
publisher BMC
record_format Article
series Current Controlled Trials in Cardiovascular Medicine
spelling doaj.art-45aa073cbb26470aab4d516c39ffbd0f2022-12-22T01:49:55ZengBMCCurrent Controlled Trials in Cardiovascular Medicine1468-67082001-10-012627828510.1186/cvm-2-6-278Therapeutic angiogenesis for cardiovascular diseaseD'Amore Patricia ANg Yin-Shan<p>Abstract</p> <p>The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to induce therapeutic angiogenesis. The results of numerous animal studies and clinical trials have offered promise for new treatment strategies for various ischemic diseases. Increased understanding of the cellular and molecular biology of vessel growth has, however, prompted investigators and clinicians alike to reconsider the complexity of therapeutic angiogenesis. The realization that formation of a stable vessel is a complex, multistep process may provide useful insights into the design of the next generation of angiogenesis therapy.</p>http://dx.doi.org/10.1186/cvm-2-6-278collateralendothelial cellsischemianeovascularizationvascular endothelial growth factor
spellingShingle D'Amore Patricia A
Ng Yin-Shan
Therapeutic angiogenesis for cardiovascular disease
Current Controlled Trials in Cardiovascular Medicine
collateral
endothelial cells
ischemia
neovascularization
vascular endothelial growth factor
title Therapeutic angiogenesis for cardiovascular disease
title_full Therapeutic angiogenesis for cardiovascular disease
title_fullStr Therapeutic angiogenesis for cardiovascular disease
title_full_unstemmed Therapeutic angiogenesis for cardiovascular disease
title_short Therapeutic angiogenesis for cardiovascular disease
title_sort therapeutic angiogenesis for cardiovascular disease
topic collateral
endothelial cells
ischemia
neovascularization
vascular endothelial growth factor
url http://dx.doi.org/10.1186/cvm-2-6-278
work_keys_str_mv AT damorepatriciaa therapeuticangiogenesisforcardiovasculardisease
AT ngyinshan therapeuticangiogenesisforcardiovasculardisease